Bounthavong, Mark <br/><br/>
Cost-effectiveness analysis of linezolid, daptomycin, and vancomycin in methicillin-resistant Staphylococcus aureus: complicated skin and skin structure infection using Bayesian methods for evidence synthesis.  [electronic resource] 

 -  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research   
 - 631-9 p.  digital 
<br/><br/> Publication Type: Comparative Study; Evaluation Study; Journal Article; Meta-Analysis 
<br/><br/><label>ISSN: </label>1524-4733 
<br/><br/><label>Standard No.: </label>10.1016/j.jval.2010.12.006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetamides--economics<br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anti-Infective Agents--economics<br/>Bayes Theorem<br/>Cost-Benefit Analysis<br/>Daptomycin--economics<br/>Decision Support Techniques<br/>Diagnostic Tests, Routine--economics<br/>Drug Costs<br/>Drug Therapy, Combination<br/>Health Services Research<br/>Hospital Costs<br/>Humans<br/>Linezolid<br/>Methicillin-Resistant Staphylococcus aureus--pathogenicity<br/>Middle Aged<br/>Models, Economic<br/>Outcome and Process Assessment, Health Care--economics<br/>Oxazolidinones--economics<br/>Staphylococcal Skin Infections--diagnosis<br/>Treatment Outcome<br/>United States<br/>Vancomycin--economics<br/>Young Adult